Clin2
NCT05602142Possibly a fitNot yet recruiting

PET scan dye for measuring brain inflammation in ALS

ALS

Part of Brain & nervous system clinical trials.

This study tests a special PET scan dye that may show inflammation in the brain, which could help doctors better understand ALS. You'll receive the dye and have a scan to see if it's safe and useful for measuring brain activity in ALS.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • You must have a diagnosis of ALS (or be a healthy volunteer without ALS).
  • Your breathing must be strong enough (at least 50% of normal for your age, height, and sex).
  • You must be able to lie flat on your back for about one hour for the scan.
  • You must have a caregiver who can help you and accompany you to visits.
  • You must be willing to avoid certain medications (like anti-inflammatories) before the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04396873Recruiting· Phase 1
PET brain scan study of inflammation markers in neurodegeneration

This Phase 1 study tests a PET scan to measure inflammation-related changes in the brain using a medication called ketoprofen. It may help researchers understand which people with certain brain diseases could benefit from treatments aimed at inflammation.

Bethesda, Maryland
NCT06129838Recruiting
Inflammation in Alzheimer's disease using a brain scan

This study uses a special PET scan to look for inflammation in the brains of people with Alzheimer's or related dementias. It may help researchers understand how inflammation affects memory and thinking problems.

St Louis, Missouri
NCT06891716Recruiting· Early Phase 1
PET scan for TDP-43 proteinopathies

This study tests a new PET scan dye that may help see TDP-43 protein buildup in the brain, which is linked to certain dementias and ALS. It aims to improve diagnosis and tracking of these conditions.

Amsterdam
NCT05395624Recruiting· Phase 1/Phase 2
Safety imaging study of a PET tracer in ALS, Alzheimer, MS, Parkinson

This early-phase study tests the safety of a radioactive tracer (“18F-OP-801”) and how the tracer moves through the body (biodistribution) in people with ALS, Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and in healthy volunteers. It also measures how the body processes the tracer (“pharmacokinetics”) to support future studies.

San Francisco, California
NCT05582200Recruiting
PET brain scan to study inflammation cells in Alzheimer’s

This study uses a special PET brain scan to look at two types of brain immune cells in people with Alzheimer’s. It may help researchers better understand Alzheimer’s and how these cells change over time.

Houston, Texas
NCT06999434Recruiting· Phase 1
Testing a new PET scan for nerve coating damage

This study uses a special PET scan tracer to look at the protective coating of nerves in the brain. It aims to help doctors see and measure damage to this coating, which can happen in diseases like multiple sclerosis. The trial is open to healthy volunteers to test this new imaging method.

New Haven, Connecticut

Hear when a new ALS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.